Peregrine Capital Management LLC Invests $3.83 Million in LivaNova PLC $LIVN

Key Points

• Peregrine Capital Management initiated a new position in LivaNova, buying 62,242 shares worth approximately $3.83 million, equal to about 0.11% of the company at the end of the quarter.
• Several large asset managers (Millennium, Artisan, Wellington, AQR, Dimensional) have materially increased stakes, and institutional investors now own about 97.64% of LivaNova stock.
• LivaNova beat quarterly estimates (EPS $0.86 vs. $0.80; revenue $360.9M vs. $354.3M, +12.2% YoY), provided FY2026 guidance of 4.15–4.25 EPS, and holds a consensus analyst stance of Moderate Buy with an average target of $74.78.

Peregrine Capital Management LLC acquired a new position in LivaNova PLC (NASDAQ:LIVN - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 62,242 shares of the company's stock, valued at approximately $3,830,000. Peregrine Capital Management LLC owned approximately 0.11% of LivaNova at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Millennium Management LLC increased its stake in shares of LivaNova by 22.4% in the 3rd quarter. Millennium Management LLC now owns 2,969,814 shares of the company's stock worth $155,559,000 after purchasing an additional 544,033 shares in the last quarter. Artisan Partners Limited Partnership boosted its holdings in LivaNova by 94.5% in the 3rd quarter. Artisan Partners Limited Partnership now owns 2,427,045 shares of the company's stock worth $127,129,000 after buying an additional 1,179,436 shares during the period. Wellington Management Group LLP boosted its holdings in LivaNova by 83.5% in the 3rd quarter. Wellington Management Group LLP now owns 2,345,516 shares of the company's stock worth $122,858,000 after buying an additional 1,067,349 shares during the period. AQR Capital Management LLC boosted its holdings in LivaNova by 30.5% in the 2nd quarter. AQR Capital Management LLC now owns 2,049,820 shares of the company's stock worth $92,201,000 after buying an additional 478,525 shares during the period. Finally, Dimensional Fund Advisors LP boosted its holdings in LivaNova by 6.6% in the 3rd quarter. Dimensional Fund Advisors LP now owns 1,721,173 shares of the company's stock worth $90,154,000 after buying an additional 106,889 shares during the period. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on LIVN. Stifel Nicolaus set a $80.00 target price on shares of LivaNova in a report on Wednesday, February 25th. Needham & Company LLC upped their target price on shares of LivaNova from $64.00 to $81.00 and gave the stock a "buy" rating in a report on Wednesday, February 25th. Weiss Ratings reaffirmed a "sell (d+)" rating on shares of LivaNova in a report on Friday, March 27th. The Goldman Sachs Group reaffirmed a "neutral" rating and issued a $66.00 target price on shares of LivaNova in a report on Friday, January 9th. Finally, Barclays upped their target price on shares of LivaNova from $67.00 to $73.00 and gave the stock an "equal weight" rating in a report on Friday, February 27th. Seven analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $74.78.

LivaNova Trading Down 1.4%

Shares of LivaNova stock opened at $64.20 on Friday. The company has a fifty day moving average of $64.71 and a 200 day moving average of $61.53. LivaNova PLC has a fifty-two week low of $35.00 and a fifty-two week high of $71.92. The company has a market capitalization of $3.51 billion, a P/E ratio of -14.39 and a beta of 0.97. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.16 and a current ratio of 1.36.

LivaNova (NASDAQ:LIVN - Get Free Report) last released its quarterly earnings data on Wednesday, February 25th. The company reported $0.86 EPS for the quarter, beating the consensus estimate of $0.80 by $0.06. LivaNova had a negative net margin of 17.46% and a positive return on equity of 16.54%. The business had revenue of $360.92 million during the quarter, compared to the consensus estimate of $354.31 million. During the same quarter in the prior year, the firm earned $0.81 EPS. The business's revenue was up 12.2% on a year-over-year basis. LivaNova has set its FY 2026 guidance at 4.150-4.250 EPS. On average, sell-side analysts anticipate that LivaNova PLC will post 3.66 earnings per share for the current fiscal year.

LivaNova Profile

LivaNova plc is a global medical technology company that develops and manufactures products and therapies for the cardiac surgery and neuromodulation markets. Headquartered in London, United Kingdom, and Houston, Texas, LivaNova serves hospitals, clinics and healthcare providers in more than 100 countries. The company's primary focus lies in advancing patient care through innovations in heart–lung bypass, cardiac preservation, circulatory support and neurostimulation therapies.

The Cardiac Surgery business unit offers a comprehensive portfolio of products used in cardiopulmonary bypass procedures, including oxygenators, heart–lung machines, arterial filters, cannulae and sutureless heart valves.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.